Work

Abstract 6025: ABBV-514: an afucosylated CCR8 specific antibody that targets and eliminates key immunosuppressive tumor regulatory T cells

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-6025

Authors: Amanda Schmidt Paustian, Linlin Guo, Weiguo Feng, Ryan Duggan, Mitra Bhattacharyya, Andrew McCluskey, Kelsey Gallant, Christopher Negron, Michael McDevitt, Cyril Ramathal, Diana Chen, Maulik Patel, Heath Smith, Keith Hamel, Julie Wilsbacher

Institutions: AbbVie (United States), Daiichi Sankyo (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409633857

Cites:

Cited by: 1

Related to: 10